The store will not work correctly when cookies are disabled.
4-[(9H-Purin-6-ylthio)methyl]-benzenemethanol
ID: ALA4745322
PubChem CID: 112630461
Max Phase: Preclinical
Molecular Formula: C13H12N4OS
Molecular Weight: 272.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: OCc1ccc(CSc2ncnc3[nH]cnc23)cc1
Standard InChI: InChI=1S/C13H12N4OS/c18-5-9-1-3-10(4-2-9)6-19-13-11-12(15-7-14-11)16-8-17-13/h1-4,7-8,18H,5-6H2,(H,14,15,16,17)
Standard InChI Key: NKCFNMFPDQVQIG-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
12.1285 -19.5094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1274 -20.3289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8354 -20.7379 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8336 -19.1005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5422 -19.5058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5470 -20.3244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3271 -20.5728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8044 -19.9077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3193 -19.2483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8312 -18.2833 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.1223 -17.8768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4158 -18.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7106 -17.8802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0046 -18.2902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0066 -19.1083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7205 -19.5146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4236 -19.1023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3007 -19.5200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5912 -19.1144 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.33 | Molecular Weight (Monoisotopic): 272.0732 | AlogP: 2.14 | #Rotatable Bonds: 4 |
Polar Surface Area: 74.69 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.91 | CX Basic pKa: 3.54 | CX LogP: 1.78 | CX LogD: 1.78 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.56 | Np Likeness Score: -0.87 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |